Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
158.77
+1.48 (0.94%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Revvity Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 5, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Revenue Revenue Growth | 2,912 | 2,856 | 2,755 | 2,751 | 3,312 | 3,828 |
Revenue Growth | 4.05% | 3.67% | 0.16% | -16.95% | -13.48% | 43.73% |
Gross Profit Gross Profit Growth | 1,601 | 1,564 | 1,538 | 1,540 | 1,990 | 2,469 |
Operating Income Operating Income Growth | 463.6 | 435.59 | 409.79 | 381.5 | 827.89 | 1,415 |
Net Income Net Income Growth | 237.55 | 241.2 | 270.39 | 693.09 | 569.18 | 943.16 |
Earnings Per Share EPS Growth | 2.09 | 2.07 | 2.20 | 5.56 | 4.51 | 8.08 |
EPS Growth | -11.50% | -5.78% | -60.48% | 23.32% | -44.22% | 24.35% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 5, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Life Sciences Life Sciences Growth | 1,445 | 1,431 | 1,399 | 1,458 | 1,293 | 895.87 |
Total Diagnostics Total Diagnostics Growth | 1,466 | 1,425 | 1,356 | 1,292 | 2,019 | 2,932 |
Revenue (Total) Revenue (Total) Growth | 2,912 | 2,856 | 2,755 | 2,751 | 3,312 | 3,828 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 5, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Cash & Investments Cash & Investments Growth | 1,023 | 947.72 | 1,190 | 1,616 | 464.54 | 637 |
Total Debt Total Debt Growth | 3,342 | 3,398 | 3,326 | 4,065 | 4,595 | 5,161 |
Net Cash (Debt) Net Cash Growth | -2,319 | -2,450 | -2,136 | -2,449 | -4,131 | -4,524 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -20.51 | -21.02 | -17.39 | -19.62 | -32.67 | -38.77 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 5, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 627.63 | 582.93 | 628.3 | 91.27 | 679.81 | 1,411 |
Capital Expenditures CapEx Growth | -69.52 | -73.52 | -86.65 | -81.37 | -85.63 | -86.02 |
Free Cash Flow Free Cash Flow Growth | 558.11 | 509.41 | 541.65 | 9.9 | 594.18 | 1,325 |
Free Cash Flow Growth | 10.96% | -5.95% | 5369.01% | -98.33% | -55.15% | 59.89% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 5, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Gross Margin | 54.98% | 54.77% | 55.81% | 55.98% | 60.08% | 64.51% |
Operating Margin | 15.92% | 15.25% | 14.87% | 13.87% | 25.00% | 36.97% |
Pretax Margin | 8.96% | 9.39% | 11.47% | 6.65% | 19.68% | 31.44% |
Profit Margin | 8.16% | 8.45% | 9.81% | 25.20% | 17.19% | 24.64% |
FCF Margin | 19.17% | 17.84% | 19.66% | 0.36% | 17.94% | 34.61% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.280 | 0.280 | 0.280 | 0.280 | 0.280 | 0.280 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.18% | 0.29% | 0.25% | 0.26% | 0.20% | 0.14% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
PE Ratio | 75.80 | 45.48 | 50.41 | 19.46 | 31.12 | 26.90 |
Forward PE | 28.15 | 18.36 | 22.42 | 24.28 | 24.27 | 29.38 |
P/FCF Ratio | 31.74 | 21.53 | 25.16 | 1362.04 | 29.81 | 19.15 |
PS Ratio | 6.08 | 3.84 | 4.95 | 4.90 | 5.35 | 6.63 |